Behaviorálny a experimentálny ekonomický tím MZSR

Drug policy

By applying behavioural approaches to the medicines policy project, we have the ambition, in collaboration with foreign partners, to streamline the running of the healthcare system in the broad area of healthcare delivery.

In aspects such as misinformation, non-adherence of patients, over-prescription of medicines, our task is to define the obstacles, to find solutions, recommendations that will lead to increased efficiency in the provision of health care and reasonable savings of finances that can be allocated more easily to where they are needed.

  • AMR - antimicrobial resistance occurs when bacteria, viruses, fungi, parasites begin to resist the antimicrobial agents that are designed to treat them
  • ATBs - antibiotics lose their ability to act against bacteria as bacteria lose their sensitivity to ATBs
  • misinformation affects patients' attitudes towards their condition, which is closely related to the ineffectiveness of therapy
  • the misconception of ATB use as a panacea
  • over-prescription and over-consumption of antibiotics accelerates antibiotic resistance
  • Improper adherence to patient treatment leads not only to inefficient consumption of medications, but also to endangerment of self and others as a result of building AMR
  • AMR is a global problem, it affects all of us
  • it occurs in people whether or not the ATB in question has been used by the individual in the past - it is not the individual's problem
  • routine operations become a major risk
  • the most common cause of death by 2050
  • market and development of new ATBs stagnates
  • ATBs available today will not be able to treat infections
  • define barriers to patient adherence and ATB prescription
  • slow the spread of antibiotic resistance
  • set up options and tools for patients in self-management of diseases related to ATB overuse